Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Moderate to Severe Rheumatoid Arthritis
.
Show all posts
Showing posts with label
Moderate to Severe Rheumatoid Arthritis
.
Show all posts
Thursday, January 23, 2020
FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis
›
In continuation of my update on Rinvoq (upadacitinib) AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company...
Friday, March 22, 2019
AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
›
In continuation of my update on upadacitinib AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has a...
›
Home
View web version
